SIU Congress 2016: Kidney Cancer, Biopsy should not be routinely performed - Session Highlights

Buenos Aires, Argentina ( Fernando Secin, Assistant Professor at the University of Buenos Aires School of Medicine and at CEMIC University Hospital discussed why renal biopsies should not be done. Outcomes can be non-diagnostic in up to 50% of biopsies performed. Taking into the learning curve, diagnostic accuracy improves over time. Technical limitations include imaging, ability to perform biopsy and pathological interpretation of the biopsies. Complications from University of Toronto can be up to 10%. While tumor seeding is a concern no reports have been published since 1992 and do not represent a significant concern. Cost effectiveness research have shown surgery leads to more life expectancy while biopsy is more cost effective. However, this research compares all biopsies to all surgeries which may have inherent selection bias confounding results. Grades of recommendation for accepted indications for renal biopsy at last year SIU gave it a grade C and the debate remains with renal biopsy performed in select rather than all patients.

World Urological Oncology Federation Symposium at the SIU Congress 2016 - October 20 - 23, 2016 – Buenos Aires, Argentina

Written By: Stephen B. Williams, M.D., Assistant Professor in Urology, The University of Texas Medical Branch, Galveston, TX. and Ashish Kamat, M.D. Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.